Brain Cancer

Enhanced Reimbursement Incentives for Generic Cancer Drugs Found Not to Affect Prescribing Patterns

By

Randi Hernandez

Publish Date May 8, 2019

Critics of the study say they are not surprised by the study’s conclusions, as oncologists make treatment decisions based on best treatment course, not money.

Combining CAR-T and BiTE in Models of Glioblastoma Multiforme

By

Stephen Cho

Publish Date April 25, 2019

This study involved the engineering of CAR-T cells specific for the EGFRvIII antigen to also secrete bispecific T cell engagers (BiTEs) against wild-type EGFR.

Clinician Interaction Scored High, Some Discussion Topics Did Not in Patient Assessment of Quality of Care

By

Megan Garlapow, PhD

Publish Date December 18, 2018

In a survey of patients’ perceptions, doctor/nurse interactions were rated high; however, some specific topics for discussion were not rated as high.

CNS Tumors in Childhood: Predicting Successful Independence in Adult Life

By

Bette Weinstein Kaplan

Publish Date October 1, 2018

Researchers at St Jude Children’s Research Hospital sought to determine what indicators in survivors of CNS tumors can predict the survivor’s ability to live independently as an adult.

Multiple Treatment Modalities for Brain Metastasis in Patients With EGFR-mutant Non-small Cell Lung Cancer

By

Haiyang Wang, Xiaoqing Yu, Yun Fan, et al.

Publish Date May 25, 2018

[OncoTargets and Therapy] Management of brain metastases in patients with EGFR-mutant NSCLC is controversial. In this study, researchers find combination and sequential treatment with EGFR-TKIs, chemotherapy, and radiotherapy is beneficial.

Brain Cancer Clinical Trials

Brain Cancer Treatment Regimens

View detailed drug regimens for the treatment of brain cancer, including treatments such as temozolomide, carboplatin, and methotrexate.

Clinical Pathway Program Promotes Clinical Trial Enrollment

A retrospective analysis of inquiries via EAPathways determined how likely the tool was to encourage patient enrollment in clinical trials.

Addressing the Need for Palliative Care Integration Into Phase 1 Clinical Trials

Researchers argue that palliative care integration into treatment regimens contribute to improving the quality of life for patients in phase 1 clinical trials.

Nurse-Led Telephone Program Maintains Dose Intensity of Immunochemotherapy for Chronic Lymphocytic Leukemia

FORTIS, a phase 3 randomized study, evaluated the effects of dose intensity of the frontline fludarabine/cyclophosphamide/rituximab on progression-free and overall survival in adult patients with CLL.

Pretreatment BMI Influences Weight Changes After Adjuvant Chemotherapy for Early-Onset Breast Cancer

Using a cohort of women from the POSH Study, researchers sought to determine risk factors for changes in weight among younger, premenopausal women receiving adjuvant chemotherapy for early-stage breast cancer.